Pluri Inc

Research Pluri Inc (PLUR) on Bullrun: market cap USD 23.20M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPLUR
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 23.20M
• Financial periodFY2025
• RevenueUSD 1.34M
• Revenue growth309.8%
• Net incomeUSD 23.25M
• Free cash flow-USD 19.83M
• Gross margin49.0%

Valuation Snapshot

latest market cap is USD 23.20M.

About Pluri Inc

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform.

Frequently asked questions

What is Pluri Inc's market cap?

Pluri Inc's market capitalization is USD 23.20M.

What does Pluri Inc do?

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries.